Dr Anna Lohning

Dr Lohning’s research background encompasses both analytical chemistry as well as structural biology including modelling of protein-ligand interactions for drug design using a range of molecular modelling techniques. In particular, she has conducted investigations into mechanisms of action of natural compounds, anti-cancer and using novel strategies to combat bacterial infections such as design of anti-adhesives. Other emerging areas of interest include gut microbiome and its impact on health and disease, She has considerable experience in theoretical chemistry and molecular modelling techniques (molecular dynamics simulations etc) which have facilitated a number of recent multi-disciplinary, international and national collaborations. Appointed to an Academic Post at Bond University in 2007 she was appointed Bond University's PI in a joint venture evaluating illicit drugs in wastewater as part of a NIRAP/QLD Smart State Grant to the value of $135,000. Dr Lohning is a member of the Centre for Urology Research, led by Prof. Russ Chess-Williams as well as the Bond University Human Research Ethics and Biosafety Committees. Dr Lohning’s research on ‘ginger as an antiemetic’ has led to further involvement with the clinical SPICE Trial (an NHMRC-funded clinical trial led by Prof. Liz Isenring at Bond University). This work further led to an international collaborations with researchers from Japan and Switzerland in the area of Diabetes research as well as a number of national collaborations. She was awarded Institutional Research Seeding & equipment Grants valued over $25,000) and has over 450 citations from 15 publications in high quality peer-reviewed journals. As of 2018, Dr Lohning currently supervises 3 PhD students while also co-coordinator for the Honours program in the Faculty of Health Sciences and Medicine.